Assessing Response of High-Grade Gliomas to Immune Checkpoint Inhibitors.


BACKGROUND Immunotherapeutic agents, especially checkpoint inhibitors, have emerged as the mainstay of therapy for several solid and hematological malignancies. These therapies are under investigation for the treatment of high-grade gliomas and brain metastases. METHODS This article reviews the unique challenges encountered when evaluating changes on… (More)


5 Figures and Tables

Slides referencing similar topics